Table 1. Inclusion and exclusion criteria.

	Inclusion Criteria	Exclusion Criteria
Population	Human beings infected by HIV Human beings having AIDS Human beings with high risk of being infected by HIV	Subjects are not human beings Subjects do not have HIV/AIDS Subjects not having high risk of being infected by HIV
Intervention	The 12 prioritised EBIs of Positive Pathways initiative: • Regular HIV testing for at risk groups • Rapid access to testing services • Rapid ART intervention • One stop shop model • Emergency advice service • Access to mental health services • Role of the pharmacist • Role of the care navigators • Individualised plan of care • Structured follow-up • Diagnosis & management of co-infections & co-morbidities	Interventions not according to the inclusion criteria, for example: • HIV/AIDS treatment being investigated only in the clinical trial setting • HIV/AIDS management model only been developed theoretically and not yet implemented in the real-world setting
Outcome	Implementation science outcomes from Proctor et al [23]: • Adoption • Acceptability • Appropriateness • Feasibility • Fidelity • Penetration • Sustainability • Implementation costs Other outcomes with regard to effectiveness of the interventions, such as: • Linkage to care • Adherence • Retention to care	Outcomes other than those defined in the inclusion criteria
Study Design	Review paper Quantitative studies and qualitative studies (such as RCTs and observational studies) Hybrid (type 1 and type 2) studies from Curran et al. [22]	Meta-analysis Letter to editor Newspaper Editorial Comment Opinion paper
Geographic Scope	Europe (continent), EU5 (UK, Germany, France, Italy, Spain), USA, Canada, Australia	Areas other than those specified in the inclusion criteria

AIDS, acquired immunodeficiency syndrome; ART, antiretroviral therapy; EBI, evidence-based intervention; HIV, human immunodeficiency virus; RCT, randomised controlled trial.